Table 2 Relationship between advanced NSCLC prognosis and GPS and serum tumor markers in 138 patients

GPS

0

1

0.01*

1

0.03*

1

0.02*

1

0.02*

1

0.7(0.4–0.9)

0.8(0.5–0.9)

0.8(0.5–0.9)

0.8(0.4–0.9)

2

0.5(0.2–0.8)

0.6(0.2–0.8)

0.5(0.3–0.8)

0.5(0.2–0.9)

CYFRA21-1 (>3.3 ng/ml)

0.6(0.5–0.9)

0.03*

0.7(0.5–1.0)

0.08

0.7(0.3–0.9)

0.04*

0.8(0.5–1.0)

0.07

CEA (>5 ng/ml)

0.7(0.4–1.1)

0.13

0.7(0.5–1.2)

0.17

0.8(0.5–1.1)

0.19

0.8(0.6–1.3)

0.19

TPS (>80 U/l)

0.7(0.5–0.9)

0.04*

0.7(0.5–1.1)

0.12

0.8(0.5–1.0)

0.05

0.8(0.4–1.1)

0.13